Tag Archives: Margaret Curnutte

Clinical Integration of Next Generation Sequencing in patient care: experts tackle three key policy areas

As techniques such as next generation sequencing, which determines the precise order of the nucleotides that make up DNA, are used in patient diagnosis and treatment, three critical policy areas remain ill-defined: Regulation by the U.S. Food and Drug Administration … Continue reading

Posted in Bioeconomy, Genomics, Health Policy | Tagged , | Leave a comment